Glow Holdings, Inc. (GLOH) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 28.57 means the share price is 28.57 times one year of earnings per share.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerGlow Holdings, Inc. (GLOH) trades at $0.02. Glow Holdings Inc. operates GlohCo, an AI-powered healthcare software platform in the United States. Sector: Financials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for GLOH: GLOH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
Glow Holdings, Inc. (GLOH) Financial Services Profile
Glow Holdings Inc., operating in the Financial Services sector as a shell company, focuses on its AI-powered healthcare software, GlohCo. The platform analyzes medical data to predict patient relapse and readmission, offering integration with electronic health record systems and compliance support for healthcare institutions in the United States.
What Is the Investment Thesis for GLOH?
Glow Holdings Inc. presents a speculative investment opportunity due to its focus on AI-powered healthcare solutions. The company's GlohCo platform, designed to predict patient relapse and readmission, addresses a significant need in the healthcare industry. However, with a small market capitalization of $0.01 billion and a beta of -2.14, the stock exhibits high volatility and risk. The absence of a dividend further reduces its appeal to income-seeking investors. The success of Glow Holdings hinges on the adoption and effectiveness of its GlohCo platform, as well as its ability to navigate the complex regulatory landscape of the healthcare industry.
Based on FMP financials and quantitative analysis
GLOH Key Highlights
Market capitalization of $0.01 billion indicates a micro-cap company with high growth potential but also significant risk.
- Beta of -2.14 suggests the stock price moves inversely to the market, potentially offering diversification benefits during market downturns, but also indicating idiosyncratic risks.
- The company operates GlohCo, an AI-powered healthcare software platform, indicating a focus on innovative technology within the healthcare sector.
- GlohCo integrates with existing electronic health record systems, facilitating adoption by healthcare providers.
- The company's platform supports compliance for hospitals, telehealth providers, and research institutions, addressing a critical need in the healthcare industry.
Who Are GLOH's Competitors?
GLOH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MTRI Metro Inc. | $15.24 | -0.26% | $889M | 38 5-pillar |
| DMII Drugs Made In America Acquisition II Corp. | $10.26 | +0.29% | $654M | 49 5-pillar |
| BCSS Bain Capital GSS Investment Cor | $10.41 | +0.68% | $608M | 55 5-pillar |
| CEPF Cantor Equity Partners IV, Inc. | $10.32 | -0.00% | $590M | 50 5-pillar |
| UMAC UMAC | $9.61 | -4.28% | $499M | — |
| NPAC New Providence Acquisition Corp. III | $10.59 | +0.14% | $407M | 50 5-pillar |
| CLBR Colombier Acquisition Corp. | $10.03 | -0.20% | $401M | 52 5-pillar |
| TACO Berto Acquisition Corp. | $10.53 | +0.10% | $395M | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GLOH's Key Strengths?
AI-powered platform with predictive analytics capabilities.
- Integration with existing electronic health record systems.
- Focus on reducing patient relapse and readmission rates.
- Support for regulatory compliance in the healthcare industry.
What Are GLOH's Weaknesses?
Small market capitalization and limited financial resources.
- Dependence on the success of a single product, GlohCo.
- Limited brand recognition and market presence.
- Pending AI analysis creates uncertainty about the platform's effectiveness.
What Could Drive GLOH Stock Higher?
GLOH catalyst: Completion and publication of AI analysis results, which could validate the effectiveness of the GlohCo platform.
- Increasing adoption of AI-powered healthcare solutions by hospitals and telehealth providers.
- Potential partnerships with major healthcare organizations to implement GlohCo.
What Are the Key Risks for GLOH?
Rich valuation — a P/E of 28.57 runs well above the Financial Services sector’s ~17.80x, leaving little room for a miss.
- Failure to achieve widespread adoption of the GlohCo platform.
- Inability to compete with larger, more established healthcare IT vendors.
- Changes in healthcare regulations that could impact the company's business model.
- Negative beta indicating sensitivity to market downturns and idiosyncratic risks.
- Limited financial resources may hinder growth and expansion efforts.
What Are the Growth Opportunities for GLOH?
- Expansion into Telehealth: Glow Holdings can capitalize on the growing telehealth market by integrating GlohCo with telehealth platforms. The telehealth market is projected to reach $550 billion by 2027, driven by increasing access to healthcare and convenience for patients. By offering AI-powered risk predictions within telehealth settings, Glow Holdings can enhance remote patient monitoring and improve outcomes, differentiating itself from competitors.
- Partnerships with Hospitals: Collaborating with hospitals to implement GlohCo within their existing infrastructure presents a significant growth opportunity. Hospitals are increasingly seeking AI solutions to improve efficiency, reduce readmissions, and enhance patient care. By demonstrating the value of GlohCo through pilot programs and case studies, Glow Holdings can secure long-term contracts and expand its market reach.
- Development of Personalized Medicine Applications: Leveraging the data collected by GlohCo, Glow Holdings can develop personalized medicine applications that tailor treatment plans to individual patient needs. The personalized medicine market is expected to reach $2.4 trillion by 2030, driven by advancements in genomics and data analytics. By offering personalized risk predictions and treatment recommendations, Glow Holdings can improve patient outcomes and gain a competitive edge.
- Geographic Expansion: Expanding its operations beyond the United States presents a significant growth opportunity for Glow Holdings. The global healthcare market is vast and diverse, with varying levels of AI adoption and regulatory requirements. By targeting specific regions with favorable market conditions and adapting GlohCo to local needs, Glow Holdings can diversify its revenue streams and accelerate its growth.
- Integration with Wearable Devices: Integrating GlohCo with wearable devices, such as smartwatches and fitness trackers, can provide real-time patient data and enhance risk predictions. The wearable device market is experiencing rapid growth, driven by increasing consumer awareness of health and wellness. By leveraging wearable data, Glow Holdings can gain a more comprehensive understanding of patient health and provide more personalized interventions.
What Threats Does GLOH Face?
- Intense competition from established healthcare IT vendors and AI startups.
- Complex regulatory requirements and data privacy concerns.
- Potential for technological obsolescence.
- Negative beta indicating sensitivity to market downturns.
What Are GLOH's Competitive Advantages?
- Proprietary AI algorithms for predicting patient relapse and readmission.
- Integration with existing electronic health record systems, creating switching costs for customers.
- Compliance support for hospitals, telehealth providers, and research institutions.
- First-mover advantage in the AI-powered healthcare software market.
What Does GLOH Do?
Glow Holdings Inc., formerly known as GlobalOne Real Estate, Inc., underwent a transformation in August 2011 to focus on AI-driven healthcare solutions. Incorporated in 1997 and based in Houston, Texas, the company operates GlohCo, an AI-powered healthcare software platform designed to improve patient outcomes and reduce healthcare costs. GlohCo ingests and analyzes diverse data types, including medical records, behavioral data, and wearable sensor data, to generate risk predictions for patient relapse, hospital readmission, and other high-cost health events. The platform's capabilities extend to seamless integration with existing electronic health record (EHR) systems, ensuring compatibility with established healthcare workflows. Furthermore, GlohCo supports compliance with regulatory requirements for hospitals, telehealth providers, and research institutions, addressing a critical need in the healthcare industry. Glow Holdings aims to provide healthcare providers with actionable insights derived from AI, enabling them to deliver more proactive and personalized care, ultimately improving patient outcomes and reducing the financial burden on the healthcare system.
What Products and Services Does GLOH Offer?
- Operates GlohCo, an AI-powered healthcare software platform.
- Ingests and analyzes medical, behavioral, and wearable data.
- Delivers risk predictions for patient relapse and readmission.
- Integrates with existing electronic health record systems.
- Supports compliance for hospitals, telehealth providers, and research institutions.
- Provides actionable insights to healthcare providers for proactive patient care.
How Does GLOH Make Money?
- Generates revenue through licensing fees for the GlohCo platform.
- Offers subscription-based access to GlohCo's AI-powered analytics.
- Provides customized integration services for electronic health record systems.
- Potentially generates revenue through data analytics and personalized medicine applications.
What Industry Does GLOH Operate In?
Glow Holdings Inc. operates within the rapidly evolving healthcare technology sector, where AI and machine learning are increasingly being adopted to improve patient care and reduce costs. The market for AI in healthcare is projected to experience substantial growth, driven by factors such as the increasing volume of healthcare data, the need for more efficient healthcare delivery, and the growing adoption of electronic health records. However, the industry is also characterized by intense competition, complex regulatory requirements, and the need for robust data security and privacy measures. Glow Holdings competes with established healthcare IT vendors and emerging AI startups, requiring continuous innovation and strategic partnerships to gain market share.
Who Are GLOH's Key Customers?
- Hospitals seeking to reduce readmission rates and improve patient outcomes.
- Telehealth providers looking to enhance remote patient monitoring and care.
- Research institutions conducting clinical trials and healthcare studies.
- Healthcare organizations seeking to comply with regulatory requirements.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
Company Profile
Glow Holdings, Inc. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Las Vegas, United States.
Key Financial Metrics
Return on equity for Glow Holdings, Inc. stands at 13.1%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -3.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.07 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -0.5%, the inverse of the P/E and a quick read on earnings relative to price.
GLOH Financials
Bull Case vs Bear Case
Bull Case
- AI-powered platform with predictive analytics capabilities.
- Integration with existing electronic health record systems.
- Focus on reducing patient relapse and readmission rates.
- Support for regulatory compliance in the healthcare industry.
Bear Case
- Small market capitalization and limited financial resources.
- Dependence on the success of a single product, GlohCo.
- Limited brand recognition and market presence.
- Pending AI analysis creates uncertainty about the platform's effectiveness.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
GLOH Latest News
No recent news available for GLOH.
GLOH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GLOH.
Price Targets
Wall Street price target analysis for GLOH.
GLOH MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GLOH; grades run from A+ (80-100) to F (below 30).
GLOH OTC Market Information
GLOH trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
GLOH Financials Stock FAQ
Is GLOH a good stock to buy?
Stock Expert AI does not rate GLOH buy, sell or hold. Glow Holdings, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the GLOH stock price today?
The last price recorded on this page for Glow Holdings, Inc. (GLOH) is $0.02, as of the Nov 18, 2026 trading session. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What do analysts say about GLOH stock?
Currently, there is no available analyst coverage for Glow Holdings Inc. (GLOH). The company's small market capitalization and limited trading volume may contribute to the lack of analyst interest. Investors should conduct their own due diligence and carefully consider the risks and potential rewards before investing in GLOH.
What are the main risks for GLOH?
Glow Holdings Inc. faces several risks, including its small market capitalization, dependence on a single product (GlohCo), and intense competition in the healthcare IT sector.
What are the key factors to evaluate for GLOH?
Evaluate GLOH on fundamentals, analyst consensus, and risk factors. P/E: 28.57x. Glow Holdings Inc. presents a speculative investment opportunity due to its focus on AI-powered healthcare solutions. Not financial advice.
How frequently does GLOH data refresh on this page?
GLOH's price is the last quote we recorded, from the Nov 18, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven GLOH's recent stock price performance?
Glow Holdings, Inc. (GLOH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: AI-powered platform with predictive analytics capabilities. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GLOH overvalued or undervalued right now?
Glow Holdings, Inc. (GLOH) trades at 28.57x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Data provided for informational purposes only.
- Information is based on limited data available.